top of page

Author: 

Editor(s):

Updated:

ULY CLINIC

ULY CLINIC

9 Septemba 2025, 05:23:25

Erythema

Erythema
Erythema
Erythema

Erythema, characterized by dilated or congested blood vessels resulting in red, scaly skin, is the most common sign of skin inflammation or irritation. It may present as localized or generalized, sudden or gradual, and its color can range from bright red in acute conditions to violet or brown in chronic cases. Differentiation from purpura is critical: erythema blanches under pressure, whereas purpura does not.


Pathophysiology

Erythema primarily results from increased perfusion in the dermal small vessels. Mechanisms include drug reactions, neurogenic changes, trauma, tissue damage, or disorders affecting vascular support structures. Rare causes include acute febrile neutrophilic dermatosis, erythema ab igne, erythema chronicum migrans, erythema gyratum repens, and toxic epidermal necrolysis.


Clinical Assessment

History Taking:
  • Onset, duration, and progression of erythema

  • Associated symptoms: pain, itching, fever, malaise, joint pain

  • Recent infections, trauma, or drug exposure

  • Family history of skin disorders or allergic conditions

  • Exposure to chemicals, UV light, or infectious contacts


Physical Examination:
  • Distribution, extent, and intensity of erythema

  • Presence of hair loss, edema, or secondary skin lesions (hives, scales, vesicles, purpura)

  • Palpation for warmth, tenderness, or crepitus

  • Special attention to skin changes in darker-skinned patients, which may appear bluish or purple


Medical Causes


Table 1: Causes of Erythema – Distinguishing Features and Key Clinical Information

Cause

Clinical Features / Distinguishing Signs

Distribution / Pattern

Other Key Information / Considerations

Allergic Reactions / Anaphylaxis

Sudden erythema, urticaria, flushing, facial edema, diaphoresis, hypotension, airway compromise

Generalized; may involve face and trunk

Life-threatening if anaphylaxis; requires epinephrine, airway management

Burns (Thermal / UV)

Redness, swelling, tenderness, possible blisters; delayed erythema for sunburn

Exposed skin areas

Assess burn depth; manage pain, fluids, infection risk

Candidiasis (Intertrigo)

Erythema with satellite pustules, scaly papular rash

Skin folds: axillae, under breasts, groin, neck, umbilicus

Common in immunocompromised or diabetic patients

Cellulitis

Red, warm, tender, swollen skin; may have systemic signs (fever)

Localized, often unilateral

Bacterial infection; risk of sepsis; treat with antibiotics

Atopic Dermatitis

Erythema with pruritus, small papules, scaling, lichenification

Flexural areas: neck, antecubital, popliteal fossa

Chronic, recurrent; may precede secondary infections

Contact Dermatitis

Acute erythema, vesicles, blisters, or ulceration after exposure

Exposed areas corresponding to irritant

Identify and remove trigger; topical steroids often required

Seborrheic Dermatitis

Dull red or yellow erythema with greasy scales

Scalp, eyebrows, nasolabial folds, chest; butterfly rash on face possible

Common in HIV patients and infants (cradle cap)

Dermatomyositis

Dusky lilac rash, Gottron’s papules over joints, heliotrope rash on eyelids

Face, neck, upper torso, nail beds

Associated with muscle weakness; often autoimmune; may require systemic steroids

Erythema Multiforme Minor

Target-like lesions, urticarial, minimal mucosal involvement

Flexor surfaces of extremities; crops

Often post-infection (HSV, Mycoplasma); self-limited

Erythema Multiforme Major / Stevens-Johnson Syndrome

Widespread symmetrical bullous lesions, mucosal erosions, fever, malaise

Generalized, often trunk and extremities

Drug reaction common; life-threatening; manage like severe burn

Erythema Nodosum

Tender, firm nodules; may be accompanied by fever, malaise, joint pain

Bilateral shins, sometimes knees, ankles, arms, buttocks

Associated with IBD, sarcoidosis, infections (strep, TB); self-limited or treat underlying cause

Gout

Tight, erythematous skin over inflamed joint

Usually first MTP joint, knees, elbows

Acute monoarthritis; treat with NSAIDs, colchicine

Lupus Erythematosus

Butterfly rash, photosensitivity, telangiectasia, purpura, mucosal ulcers

Face, sun-exposed areas

Systemic symptoms possible (fever, fatigue, arthralgia); autoimmune management

Psoriasis

Silvery-white scales over erythematous plaques, pitting nails

Elbows, knees, scalp, chest, intergluteal folds

Chronic, recurrent; systemic therapy if extensive

Rosacea

Central facial erythema, telangiectasia, papules, pustules; rhinophyma possible

Nose, cheeks, forehead, chin

Chronic, may be triggered by alcohol, heat, sun

Radiation / Drug-Induced

Dull erythema, edema; may be symmetric; timing related to exposure

Localized or generalized

Assess drug history; may require discontinuation and supportive care

Neonatal / Pediatric Rashes

Erythema toxicum neonatorum: pink papular rash, resolves spontaneously; Roseola, rubella: erythematous maculopapular rashes with fever

Trunk, extremities, face

Consider infectious causes; hospitalization if neonate has fever

Actinic Purpura (Elderly)

Well-demarcated purple macules or patches, mainly dorsal hands and forearms

Hands, forearms

Result of fragile capillaries; usually self-limited

Notes for Healthcare Professionals:
  • Always assess systemic signs such as fever, hypotension, dyspnea, and mucosal involvement.

  • Pediatric and geriatric patients may present differently; consider developmental and skin aging factors.

  • Rapid identification of life-threatening causes (anaphylaxis, SJS, severe burns) is critical.

  • Document drug history, exposures, and underlying diseases to guide management.


Emergency interventions and supportive care


Table 2: Emergency Interventions & Supportive Care for Erythema

Cause / Condition

Emergency Interventions

Supportive Care / Monitoring

Anaphylaxis / Severe Allergic Reaction

Immediate epinephrine IM; maintain airway; supplemental oxygen; IV fluids for hypotension

Monitor vitals, respiratory status, and mental status; antihistamines and corticosteroids as adjuncts

Severe Burns (Thermal / UV)

Stop burning process; assess airway if inhalation injury suspected

Cool affected area; analgesics; fluid replacement; monitor for infection and shock

Erythema Multiforme Major / SJS

Hospitalization; discontinue offending drug; supportive care similar to burn management

Fluid and electrolyte replacement; wound care; pain control; monitor for secondary infection

Cellulitis

Assess for sepsis; hemodynamic support if hypotensive

IV or oral antibiotics; monitor for progression, fever, systemic symptoms

Erythema Nodosum

Rule out systemic infection; supportive only unless underlying cause severe

NSAIDs for pain and inflammation; elevate affected limbs; treat underlying disease

Gout with Erythema

NSAIDs or colchicine for acute flare

Rest joint; apply ice; educate on diet and medications to prevent recurrence

Severe Lupus Erythematosus Flare

Hospitalization if systemic involvement; corticosteroids or immunosuppressants

Monitor renal, hematologic, and cardiac function; supportive skin care; avoid sun exposure

Neonatal / Pediatric Erythema with Fever

Assess airway, breathing, circulation; admit if sepsis suspected

Hydration; treat underlying infection; monitor vitals and perfusion

Drug-Induced Erythema

Discontinue offending agent; treat anaphylaxis if present

Symptomatic relief with antihistamines, topical corticosteroids; monitor for systemic reaction

Radiation-Induced Erythema

Usually non-emergent unless widespread skin breakdown

Topical emollients, corticosteroids; avoid further exposure; monitor for infection

Special Considerations

  • Monitor fluid and electrolyte balance in patients with extensive erythema or burns.

  • Withhold potential causative medications until the etiology is identified.

  • Consider topical or systemic corticosteroids and antibiotics as clinically indicated.


Diagnostic Workup

  • Skin biopsy for atypical lesions or suspected malignancy

  • Culture and sensitivity for infectious causes

  • Laboratory studies for systemic involvement: CBC, inflammatory markers, autoantibodies


Patient Counseling

  • Educate patients to recognize early signs of flare-ups.

  • Advise sun protection and avoidance of triggering substances.

  • Recommend skin care strategies: soothing baths, wet dressings, antihistamines, and analgesics.


Pediatric Considerations

  • Neonatal erythema (toxicum neonatorum) is self-limited.

  • Infants may develop erythema from infections, candidiasis, or dermatologic conditions.

  • Hospitalization may be warranted for neonates with fever and erythema.


Geriatric Considerations

  • Elderly patients often present with actinic purpura: well-demarcated purple macules on the hands and forearms.

  • Lesions usually resolve spontaneously.


References:
  1. Jeon HC, Choi M, Paik SH, Paik SH, Na SJ, Lee JH, Cho S. A case of assisted reproductive therapy-induced erythema nodosum. Ann Dermatol. 2010;23(3):362–364.

  2. Papagrigoraki A, Gisondi P, Rosina P, Cannone M, Girolomoni A. Erythema nodosum: Etiological factors and relapses in a retrospective cohort study. Eur J Dermatol. 2010;20(6):773–777.

  3. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. Philadelphia: Elsevier; 2015.

  4. James WD, Berger TG, Elston DM. Andrews' Diseases of the Skin: Clinical Dermatology. 13th ed. Philadelphia: Elsevier; 2019.

  5. Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. London: Elsevier; 2018.

  6. Tüzün Y, Wolf R. Erythema: Clinical manifestations and pathophysiology. Clin Dermatol. 2012;30(1):3–15.

  7. Heng MCY, Heng MK. Drug-induced erythema and dermatologic adverse reactions. Dermatol Ther. 2010;23(4):372–383.

  8. Haberman HF. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Dermatol Clin. 2011;29(2):231–240.

  9. Schwartz RA, Nervi SJ. Erythema nodosum: A sign of systemic disease. J Am Acad Dermatol. 2007;57(2):241–253.

  10. Weston WL, Morelli JG. Pediatric dermatology: Neonatal erythema and rashes in infants. Pediatr Clin North Am. 2006;53(3):503–519.

bottom of page